Sep 29

SS 29 - Intensify, Shorten, or Personalize? Modern Approaches to Post-prostatectomy RT

249 - A Randomized Phase II Study of Enhanced AR Blockade with Enzalutamide In High-Risk Patients with Biochemical Relapse Undergoing Salvage Radiation: Final Results from RTOG 3506 (STEEL)

12:30pm - 12:40pm ET

Presenter(s)

Edwin Posadas, MD - Cedars-Sinai Medical Center, Los Angeles, CA